Almost $1B Later, the US Still Can't Make a Medical Glove
The US has poured nearly $1 billion into domestic medical glove production, yet domestic manufacturing remains insufficient to meet demand.
- The US has invested nearly $1 billion in domestic medical glove production since 2020, yet domestic output remains below 5% of total demand.
- Regulatory, cost, and scalability challenges have prevented the US from matching the efficiency of overseas manufacturers.
- Automation and government incentives have not been enough to offset labor shortages and supply chain bottlenecks.
- The US remains heavily dependent on imports from Southeast Asia for medical gloves, raising supply chain resilience concerns.
A Bloomberg investigation reveals that despite nearly $1 billion in federal and private investment since 2020, the United States has failed to establish a robust domestic supply chain for medical gloves. The pandemic exposed critical vulnerabilities in global supply chains, prompting massive funding for reshoring efforts. However, regulatory hurdles, high production costs, and competition from low-cost overseas manufacturers have stymied progress. Even with advanced automation and government incentives, domestic production accounts for less than 5% of total US consumption, leaving the country dependent on imports from Southeast Asia.
The report highlights that while some new facilities have opened, they operate at a fraction of capacity due to labor shortages, supply chain bottlenecks, and the inability to match the scale and cost efficiency of established producers. Industry experts argue that without sustained investment and policy support, the US will continue to rely on foreign suppliers for this critical medical supply, raising concerns about preparedness for future health crises.
Companies face ongoing risks of supply chain disruptions for critical medical supplies.
Investments in domestic medical supply chains may not yield expected returns due to structural challenges.
The US remains vulnerable to global supply chain disruptions for essential medical equipment.
- reshoring
- the process of bringing manufacturing back to a country from overseas.
Laptops, smartphones, gaming consoles get costlier as AI fuels chip demand: Report - Anadolu Ajansı
As gas plants rise to power AI, renewable energy allies are fighting for cleaner alternatives - WRAL
AI moved in next door. For this Memphis community, life got more complicated. - The Christian Science Monitor
Macroscope | Don’t expect the rising tide of AI to lift all boats - South China Morning Post
BusinessOpenAI admits it "didn't get everything quite right" with ChatGPT Work launch and scrambles to fix UX and costs
AI Visibility Rankings Aren’t Stable – New Research Shows It’s Mostly Statistical Noise - Search Engine Journal
New research indicates AI visibility rankings are unstable and largely driven by statistical noise rather than meaningful performance differences.
Dependence on Generative Artificial Intelligence Among Medical Students and Its Association With Critical Thinking: A Cross-Sectional Study - Cureus
A cross-sectional study published in Cureus explores the dependence of medical students on generative artificial intelligence and its association with critical thinking skills.
Child Safety Requirements for Artificial Intelligence in our schools - Davis Vanguard
New requirements are being considered for the use of artificial intelligence in schools to ensure child safety. The goal is to protect students from potential AI-related risks.
Hathal Haddad: Artificial Intelligence in Interventional Radiotherapy - Oncodaily
Hathal Haddad explores the application of artificial intelligence in interventional radiotherapy for cancer treatment.
AI ResearchChina's Orca world model matches specialized robotics systems without ever seeing a single action label
China’s Beijing Academy of Artificial Intelligence unveiled Orca, a world model trained on 125,000 hours of video that predicts abstract states instead of tokens or pixels. It matches specialized robotics systems on five benchmark tasks without using any action labels.
LLMMeta's Muse Spark 1.1 outperforms GLM-5.2 in coding and costs slightly less
Meta’s Muse Spark 1.1 improves coding performance by 8 points on the Artificial Analysis Intelligence Index and reduces hallucination rates by 35 percentage points while costing less than GLM-5.2.